In a previous post, I explained our choice to turn toward chronic disease as our next frontier. More recently, we have begun a deep dive into Diabetes care. This decision has been influenced by several factors.  One is a collaboration with a large telepharmacy chain that is motivated to reshape their value proposition.  As they see it, their patients need [...]